Here you will find press releases, an image bank and you can subscribe to our releases. If you do not find what you are looking for, do not hesitate to contact us.
- Interim report January – September 2021
- Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2021
- Nomination Committee Appointed for the Annual General Meeting 2022 in Promore Pharma
- Promore Pharma receives permits to start a phase II clinical trial regarding scar prevention
- Promore Pharma announces that scientific article has been published on clinical study results with ropocamptide for venous leg ulcers